Kaymakci Bilge, Philbert Daphne, Hazen Ankie C M, Heringa Mette, Kwint Henk-Frans, Zwart Dorien L M, van Dijk Liset, Kälvemark Sporrong Sofia, Kempen Thomas G H
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Int J Clin Pharm. 2025 Apr;47(2):392-402. doi: 10.1007/s11096-024-01842-7. Epub 2024 Dec 1.
Pharmacist prescribing legislation aims to enhance healthcare quality and accessibility. However, in many countries, like the Netherlands, it has not yet been legally established.
To investigate pharmacists' perspectives on potential pharmacist prescribing in the Netherlands.
An online survey using a questionnaire that was distributed via e-mail and electronic newsletters to most practicing pharmacists in the Netherlands during October and November 2023. The questionnaire was based on previous literature, further developed during an international conference with pharmacists and piloted with Dutch pharmacists. Agreement with statements about potential prescribing models, settings, preconditions, and perceived benefits and risks was measured using a 4-point Likert scale. Data were analysed descriptively.
In total, 625 participants from community pharmacy (n = 432; 69.1%), hospital pharmacy (n = 149; 23.8%), or other/combined settings (n = 44; 7.0%) completed the questionnaire. Most pharmacists (somewhat) agreed with the introduction of an independent prescribing model with limitations (n = 538; 86.1%) or a model dependent on collaborative agreements with physicians (n = 471; 75.4%). A minority (n = 245; 39.2%) supported independent prescribing with diagnostic authority. The precondition that participants most frequently (somewhat) agreed with was access to health records (n = 607; 97.1%). The most (somewhat) agreed-upon benefits were enhanced professional position of pharmacists (n = 574; 91.8%) and reduced workload for other prescribers (n = 573; 91.7%). Increased workload for pharmacists (n = 495; 79.2%) was the most (somewhat) agreed-upon identified risk.
Pharmacists in the Netherlands are generally supportive of an independent but limited or collaborative pharmacist prescribing model. These findings support further investigations into the potential introduction of pharmacist prescribing legislation.
药剂师处方立法旨在提高医疗质量和可及性。然而，在许多国家，如荷兰，该立法尚未在法律上确立。
调查荷兰药剂师对药剂师潜在处方权的看法。
于2023年10月和11月通过电子邮件和电子通讯向荷兰大多数执业药剂师分发一份使用问卷的在线调查。该问卷基于先前的文献，在与药剂师的国际会议期间进一步完善，并在荷兰药剂师中进行了试点。使用4点李克特量表衡量对有关潜在处方模式、环境、前提条件以及感知到的益处和风险的陈述的认同度。对数据进行描述性分析。
共有625名来自社区药房（n = 432；69.1%）、医院药房（n = 149；23.8%）或其他/综合环境（n = 44；7.0%）的参与者完成了问卷。大多数药剂师（有点）同意引入有局限性的独立处方模式（n = 538；86.1%）或依赖与医生合作协议的模式（n = 471；75.4%）。少数人（n = 245；39.2%）支持具有诊断权的独立处方。参与者最常（有点）同意的前提条件是能够获取健康记录（n = 607；97.1%）。最（有点）认同的益处是药剂师专业地位的提升（n = 574；91.8%）和其他开处方者工作量的减少（n = 573；91.7%）。药剂师工作量增加（n = 495；79.2%）是最（有点）认同的已识别风险。
荷兰药剂师总体上支持独立但有限制或合作的药剂师处方模式。这些发现支持对药剂师处方立法的潜在引入进行进一步调查。
